Director TitleAgeSince
Chairman - -
Chairman - 28/06/2012
Director/Board Member - 24/12/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.25%-20.59% - - 23.15M
+0.99%+1.78%+4.07%+16.73% 49.47B
+3.71%+9.40%+486.98%+592.14% 43.61B
+5.60%+10.21%+16.76%+85.72% 39.6B
+2.70%+1.57%+33.39%+8.85% 39.29B
+2.21%+6.75%+21.31%+53.37% 32.43B
+2.23%+4.71% - - 16.84B
+0.97%+2.35%+37.75%+126.84% 16.49B
-0.11%+2.41%+6.24%+18.87% 14.01B
+0.75%+15.04%+78.59%+30.30% 12.77B
Average +2.03%+6.32%+85.64%+116.60% 29.39B
Weighted average by Cap. +2.54%+6.10%+104.25%+140.79%
Logo Pharmadax Inc.
Pharmadax Inc is a Taiwan-based company principally engaged in the development, licensing and sales of Abbreviated New Drug Application (ANDA) drugs. The Company is mainly engaged in the development of oral solid extended-release dosage forms and products. The Company's main product is the hypoglycemic product, Glyburide. The Company distributes its products to the United States.
Employees
-
  1. Stock Market
  2. Stocks
  3. 4191 Stock